Investigating the effect of apricot kernel oil cream on pain intensity and episiotomy wound healing in primiparous women
Design
A clinical trial with two intervention and placebo groups with parallel groups, triple blind, randomized, phase 2-3 for 76 patients. Random Allocation Software will be used for randomization.
Settings and conduct
This triple-blind research will be conducted in M. Al-Binin (S) and Hashminejad hospitals in Mashhad. In the intervention group, they will use apricot kernel oil cream every 12 hours for 10 nights. The placebo group will also use the placebo in the same way. The tools will include a demographic and midwifery information questionnaire, a visual pain scale, a Rida scale form and a drug side effects form, which will be evaluated within the first 24 hours after delivery, on the fifth day and one of the days during 10 to 14 it will take place after childbirth.
Participants/Inclusion and exclusion criteria
Inclusion criteria: signed informed consent; no use of drugs effective on wound healing; no diabetes.
Exclusion criteria: abnormal bleeding after delivery; not using the cream regularly; not coming for follow-up; suffering from a disease that requires the prescription of antibiotics.
Intervention groups
The intervention group consumes 30 grams of apricot kernel oil cream tubes prepared with code A or B, topically and every 12 hours, 2 cm of the product in the first 10 days after delivery.
in the control group. The placebo is a standard cold cream without apricot kernel oil and as a simple cream base, which is similar to the drug in terms of shape and can only be distinguished by the code, and the method of administration will be the same as the drug group.
Main outcome variables
Intensity of episiotomy pain; healing of episiotomy wound
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20230501058041N1
Registration date:2023-06-20, 1402/03/30
Registration timing:prospective
Last update:2023-06-20, 1402/03/30
Update count:0
Registration date
2023-06-20, 1402/03/30
Registrant information
Name
Narjes Kharazmi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3859 1511
Email address
kharazmin4001@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-07-01, 1402/04/10
Expected recruitment end date
2023-10-22, 1402/07/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effect of apricot kernel oil cream on pain intensity and episiotomy wound healing in primiparous women
Public title
Investigating the effect of apricot kernel oil cream on pain and healing of episiotomy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
The participant has informed consent.
Age between 18 and 35 years old.
Must be literate and a resident of Mashhad.
The gestational age should be 37 to 42 weeks.
Do not have a history of sensitivity or allergy to topical medications in the past
Do not use drugs effective on wound healing (glucocorticoids, anticoagulants, immunosuppressants, broad-spectrum antibiotics, and chemotherapy).
Do not be addicted to drugs.
Not diabetic
Rupture of water bag not more than 18 hours
Singleton pregnancy
No history of surgery or visible lesions in the perineum.
Body mass index should be between 19.8 and 30
Exclusion criteria:
The baby's weight should be more than 4000 grams.
Have abnormal bleeding after delivery.
Has not used the cream regularly.
Allergies and infections
Happening a new trauma.
Do not refer for follow up.
Patients with a disease need to be prescribed antibiotics.
Does not want to continue participating in the research.
Have sex in the first ten days.
Manipulate again after episiotomy repair.
Have a 3rd and 4th grade tear of the perineum
Have postpartum fever.
Childbirth with tools.
The placenta should be removed by hand.
There is a hematoma in the episiotomy area
The first stage of labor is more than 14 hours, the second stage is more than 2 hours, and the third stage is more than one hour
The baby should be admitted to the NICU
Age
From 18 years old to 35 years old
Gender
Female
Phase
2-3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Data analyser
Data and Safety Monitoring Board
Sample size
Target sample size:
76
Randomization (investigator's opinion)
Randomized
Randomization description
Blocked random assignment
In this study, permutation blocks method will be used to generate the sequence of random assignment of people to the studied groups. Random allocation sequence of people will be done using Random Allocation Software and block size of four. The permutation block method is one of the random allocation methods in which each block is selected according to the number of studied groups.
In this study, there are six blocks AABB (1), ABAB (2), ABBA (3), BBAA (4), BABA (5) and BAAB (6). One of the blocks is randomly selected. If the first block, AABB, is selected, the first and second people are assigned to group A, and the third and fourth people are assigned to group B, and this process continues until all the samples are assigned. The characteristic of this method is that the two study groups will have equal numbers.
Allocation Concealment method
Random Allocation Software
Sealed envelopes are used to hide the assignment. Based on the order of entry of the research units, the envelopes will be opened in order and the assigned group will be revealed.
In order to hide the allocation, opaque envelopes numbered consecutively (in the order of allocation sequence) were used, which will contain 2 bottles containing the solution. Medicines will be placed in the envelopes based on the random sequence of allocation by a person not involved in the research. Entering people into the study and delivering the envelopes from number 1 to 120 will be done by the researcher himself
Blinding (investigator's opinion)
Triple blinded
Blinding description
The drug and placebo are blinded by the pharmacist and the researcher and the participants will not know the contents of the package. The desired cream is prepared in containers of one shape and one color of 30 grams, and coding (A, B) will be done on the containers by a pharmacist consultant. 38 participants in each group will receive cream A or B randomly.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Mashhad University of Medical Sciences
Street address
Khorasan Razavi, Mashhad, University Street, Central Organization of Qurashi Building University
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Approval date
2023-05-30, 1402/03/09
Ethics committee reference number
IR.MUMS.NURSE.REC.1402.032
Health conditions studied
1
Description of health condition studied
Episiotomy wound
ICD-10 code
O70
ICD-10 code description
Episiotomy extended by laceration: Perineal laceration during delivery
2
Description of health condition studied
Episiotomy wound
ICD-10 code
070.0
ICD-10 code description
First degree perineal laceration during delivery
3
Description of health condition studied
Episiotomy wound
ICD-10 code
O70.1
ICD-10 code description
Second degree perineal laceration during delivery
Primary outcomes
1
Description
Reducing the pain intensity score at the episiotomy site based on the visual pain scale tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Visual tool for pain
2
Description
Reducing the redness score of the episiotomy wound based on the Rida tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida too
3
Description
Reduction of episiotomy wound edge edema score based on Rida tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida too
4
Description
Reduction of episiotomy wound bruising score based on Rida tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida too
5
Description
Reduction of episiotomy wound edge cohesion score based on Rida tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida too
6
Description
Reducing the episiotomy wound discharge score based on the Rida tool
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida too
7
Description
Wound healing based on the reduction of the mean total score of the Rida instrument
Timepoint
The first, fifth and 10 to 14 days after delivery
Method of measurement
Rida tool, observation of signs of infection (redness, secretion or purulent exudate, swelling of wound margin
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: After random allocation, the intervention group received the cream containing 10% apricot kernel oil, which was prepared and filled in 30 gram tubes with code A or B under the supervision of professors of the Faculty of Pharmacy of Mashhad University of Medical Sciences (oil extraction with a cold press machine). Local face and every 12 hours, 2 cm of the product is consumed in the first 10 days after delivery
Category
Treatment - Drugs
2
Description
Control group: The control group will be placed in the placebo group after random allocation. The placebo is a standard cold cream without apricot kernel oil and as a simple cream base, which is similar to the drug in terms of shape and can only be distinguished by the code (by the pharmacist) and the method of use will be the same as the drug group
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Mashhad Hasheminejad Hospital
Full name of responsible person
Mahboobeh Firoozi
Street address
At the end of Abu Rihan Boulevard, Shahid Muftah Boulevard, Tollab
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913199
Phone
+98 51 3891 5113
Email
nms.pr@mums.ac.ir
2
Recruitment center
Name of recruitment center
Mashhad Umm al-Binin Hospital
Full name of responsible person
Mahboobeh Firoozi
Street address
Faculty of Nursing and Midwifery, Ibn Sina Street, Doctor's Crossroad, University of Mashhad, Khorasan Razavi
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913199
Phone
+98 51 3891 5113
Email
nms.pr@mums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mahboobeh firoozi
Street address
Khorasan Razavi, Mashhad, University Street, Central Organization of Qurashi Building University
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3841 2081
Email
p.relations@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mahboobeh Firoozi
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Midwifery
Street address
Faculty of Nursing and Midwifery, Ibn Sina Street, Doctor's Crossroad, University of Mashhad, Khorasan Razavi
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913199
Phone
05138591511-3
Email
FirooziM@mums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mahboobeh Firoozi
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Midwifery
Street address
Faculty of Nursing and Midwifery, Ibn Sina Street, Doctor's Crossroad, University of Mashhad, Khorasan Razavi
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913199
Phone
05138591511-3
Email
FirooziM@mums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mahboobeh Firoozi
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Midwifery
Street address
Faculty of Nursing and Midwifery, Ibn Sina Street, Doctor's Crossroad, University of Mashhad, Khorasan Razavi
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913199
Phone
05138591511-3
Email
FirooziM@mums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available